The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Anesthesiologists designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification in Anesthesiology® and MOCA^® are registered certification marks of the American Board of Anesthesiology^®. MOCA 2.0^® is a trademark of the American Board of Anesthesiology^®.

This activity contributes to the patient safety CME requirement for the CME component of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in Anesthesiology^® (MOCA^®) program, known as MOCA 2.0^®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

This activity contributes to the Part 4: Improvement in Medical Practice requirement of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in Anesthesiology Program^® (MOCA^®), known as MOCA 2.0™. Earn up to 1.5 points for completion of the activity.

Access the course.

Quantify the scope of this problem and the tangible effects of leaving patients with residual weakness at the time of extubation.
Identify evidence-based, optimal neuromuscular blockade management strategies.
Delineate the role of reversal agents in common clinical situations.
Discuss the nuances of quantitative monitoring as means of accurately determining the level of blockade and adequate neuromuscular recovery.
Address common misconceptions regarding neuromuscular blockade management and work through historic obstacles to advancing the care of perioperative patients.
Identify techniques that can promote sustained, behavioral changes that incorporate optimal neuromuscular blockade management.

Physician anesthesiologists and care team members.

Karen B. Domino, MD, MPH; Moderator

Richard P. Dutton, MD, MBA, FASA

Heidrun Lewald, MD

Stephan R. Thilen, MD, MS

Wade A. Weigel, MD, FASA

The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists education activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

All faculty, planners, and staff have disclosed no relevant financial relationships with ineligible companies.

Internet connection, web browser version must have been released within the last three years.

Monitoring Neuromuscular Blockade

Item Details

Monitoring Neuromuscular Blockade

Additional Information:

Item Details: